I agree that this site is using cookies. You can find further informations here.
X
Freise, Kevin J.
93  results:
Search for persons X
?
1

First-in-human clinical trial results with ABBV-184, a firs..:

Peterlin, Pierre ; Saada-Bouzid, Esma ; Moskovitz, Mor...
Expert Review of Anticancer Therapy.  , 2024
Link: https://doi.org/10.1080/..
 
?
2

Single‐dose pharmacokinetics and bioavailability of a novel..:

Freise, Kevin J. ; Reinemeyer, Craig ; Warren, Katherine..
Journal of Veterinary Pharmacology and Therapeutics.  45 (2022)  S1 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
3

Margin of safety of extended‐duration transdermal buprenorp..:

Clark, Terrence P. ; Linton, Deborah D. ; Freise, Kevin J....
Journal of Veterinary Pharmacology and Therapeutics.  45 (2022)  S1 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
4

Multicentered masked placebo‐controlled phase 2 clinical st..:

Clark, Terrence P. ; Linton, Deborah D. ; Freise, Kevin J..
Journal of Veterinary Pharmacology and Therapeutics.  45 (2022)  S1 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
5

Multicentered masked placebo‐controlled phase 3 clinical st..:

Clark, Terrence P. ; Linton, Deborah D. ; Freise, Kevin J..
Journal of Veterinary Pharmacology and Therapeutics.  45 (2022)  S1 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
6

Integrated Mechanistic Model of Minimal Residual Disease Ki..:

Gopalakrishnan, Sathej ; Wierda, William ; Chyla, Brenda...
Clinical Pharmacology & Therapeutics.  109 (2020)  2 - p. 424-432 , 2020
Link: https://doi.org/10.1002/..
 
?
7

Semimechanistic Modeling to Guide Venetoclax Coadministrati..:

Alhadab, Ali A. ; Salem, Ahmed Hamed ; Freise, Kevin J.
Clinical and Translational Science.  13 (2020)  3 - p. 555-562 , 2020
Link: https://doi.org/10.1111/..
 
?
8

Power Determination During Drug Development: Is Optimizing ..:

Jones, Aksana K. ; Salem, Ahmed Hamed ; Freise, Kevin J.
CPT: Pharmacometrics & Systems Pharmacology.  8 (2019)  3 - p. 138-145 , 2019
Link: https://doi.org/10.1002/..
 
?
9

Bayesian Population Model of the Pharmacokinetics of Veneto..:

Deng, Rong ; Gibiansky, Leonid ; Lu, Tong...
Clinical Pharmacokinetics.  58 (2019)  12 - p. 1621-1634 , 2019
Link: https://doi.org/10.1007/..
 
?
10

A Phase 3 Study of Venetoclax or Placebo in Combination wit..:

Kumar, Shaji ; Harrison, Simon J. ; Cavo, Michele...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e31 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Use of depth of response to predict progression‐free surviv..:

Mangal, Naveen ; Salem, Ahmed Hamed ; Menon, Rajeev M..
Hematological Oncology.  36 (2018)  3 - p. 547-553 , 2018
Link: https://doi.org/10.1002/..
 
?
12

Are Clinical Therapeutic Protein‐Drug Interaction Studies N..:

Pang, Yinuo ; Rosebraugh, Matthew R. ; Freise, Kevin J...
The Journal of Clinical Pharmacology.  58 (2018)  10 - p. 1371-1372 , 2018
Link: https://doi.org/10.1002/..
 
?
13

Impact of ritonavir dose and schedule on CYP3A inhibition a..:

Freise, Kevin J. ; Hu, Beibei ; Salem, Ahmed Hamed
European Journal of Clinical Pharmacology.  74 (2018)  4 - p. 413-421 , 2018
Link: https://doi.org/10.1007/..
 
?
14

Relationship between response rates and median progression‐..:

Mangal, Naveen ; Salem, Ahmed Hamed ; Li, Mengyao..
Hematological Oncology.  36 (2017)  1 - p. 37-43 , 2017
Link: https://doi.org/10.1002/..
 
?
15

Quantitative Prediction of the Effect of CYP3A Inhibitors a..:

Freise, Kevin J. ; Shebley, Mohamad ; Salem, Ahmed Hamed
The Journal of Clinical Pharmacology.  57 (2017)  6 - p. 796-804 , 2017
Link: https://doi.org/10.1002/..
 
1-15